← Back to Search

Thrive Professional Learning + ParentCorps for Child Development

N/A
Waitlist Available
Led By Laurie Brotman, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant Selection Criteria: Pre-K students and families who are in the schools in 2018-2019. Only parents and students who are English or Spanish speaking will be eligible for participation in the study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 84 months
Awards & highlights

Study Summary

This trial looks at the effects of the ParentCorps program on high-poverty district schools in NYC. It includes 2 assessments of Pre-K students over 10 months, 1 assessment at the end of Kindergarten, and teacher ratings of children in Pre-K and Kindergarten. Additionally, parents will be asked to consent to the use of their children's records from Pre-K to grade 5, and to participate in surveys and focus groups.

Who is the study for?
This trial is for families with Pre-K children attending one of the 81 selected high-poverty district schools in NYC. Participants must speak English or Spanish. It's not open to those outside these schools, non-English/Spanish speakers, or teachers and principals from the sites.Check my eligibility
What is being tested?
The study tests ParentCorps within NYC's Pre-K Thrive initiative, comparing its impact when combined with Thrive Professional Learning versus Thrive alone or Inspire Professional Learning on creating supportive environments for kids.See study design
What are the potential side effects?
Since this is an educational and social support intervention rather than a medical treatment, traditional side effects are not applicable. However, there may be varying levels of stress or anxiety experienced by participants due to involvement.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a parent or pre-K student in the 2018-2019 school year and speak English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~84 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 84 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Score on Dimensional Change Card Sort (DCCS) Assessment
Score on Parental Engagement of Families Questionnaire (PEFL)
Score on Pencil Tap Assessment
+1 more
Secondary outcome measures
Score on Assessment of Children's Emotional Skills (ACES)
Score on Emotion Recognition Questionnaire (ERQ)
Score on Financial Stress Questionnaire
+3 more
Other outcome measures
Child body mass index (BMI)

Trial Design

3Treatment groups
Experimental Treatment
Group I: Thrive Professional Learning plus ParentCorpsExperimental Treatment1 Intervention
1) Professional Development, Program Training and Coaching; 2) Program for Parents of Pre-K Students; and 3) Program for Pre-K Students. The three intervention components are expected to strengthen relationships and communication between parents and teachers and promote safe, nurturing and predictable environments, which contribute to child mental health and achievement.
Group II: Thrive Professional Learning onlyExperimental Treatment1 Intervention
Best practices in Family Engagement and Social Emotional Learning and includes an experiential approach to behavior change that asks learners to take the perspective of others and consider their own beliefs and assumptions about students, families, teachers and leaders.
Group III: Inspire Professional LearningExperimental Treatment1 Intervention
Led by the NYC Department of Education. Professional Learning sessions are tailored to the needs of pre-K teachers and leaders, and include topics aligned with the district's quality standards that support child instructional goals.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
836,461 Total Patients Enrolled
Laurie Brotman, MDPrincipal InvestigatorNew York Langone Health
1 Previous Clinical Trials
570 Total Patients Enrolled

Media Library

Inspire Professional Learning Clinical Trial Eligibility Overview. Trial Name: NCT04276363 — N/A
Social Anxiety Research Study Groups: Thrive Professional Learning plus ParentCorps, Thrive Professional Learning only, Inspire Professional Learning
Social Anxiety Clinical Trial 2023: Inspire Professional Learning Highlights & Side Effects. Trial Name: NCT04276363 — N/A
Inspire Professional Learning 2023 Treatment Timeline for Medical Study. Trial Name: NCT04276363 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the ultimate purpose of this medical research?

"The primary metric of this long-term (84 months) study is the Parental Engagement in Family Living Questionnaire score. Secondary measurements include the Emotion Recognition Quiz, PROMIS-10 Survey, and PROMIS-4 Sleep Disturbance survey - all of which assess various components related to parent well being on a 5 point scale ranging from poor to excellent."

Answered by AI

What are the necessary qualifications for a participant in this clinical experiment?

"Participants eligible to join this trial should have psychological stress and fall within the ages of 4-65. The total number of enrollees sought is 3300."

Answered by AI

Can fresh participants still join this endeavor?

"According to the information published on clinicaltrials.gov, this experiment has stopped recruiting participants. The trial was first accessible on November 14th 2019 and lastly revised May 10th 2022; however, there are 125 other medical studies currently in need of individuals for their research."

Answered by AI

Is the patient pool for this research study limited to those over a certain age?

"This trial seeks participants aged between 4 and 65 years old."

Answered by AI
~1086 spots leftby Jun 2026